These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2904627)

  • 1. Ganciclovir for severe cytomegalovirus infection in transplant recipients.
    Nicholson ML; Flower AJ; Simpson A; Donnelly PK; Veitch PS; Bell PR
    Lancet; 1988 Dec 24-31; 2(8626-8627):1501-2. PubMed ID: 2904627
    [No Abstract]   [Full Text] [Related]  

  • 2. Ganciclovir for severe cytomegalovirus infection in transplant recipients.
    Rostoker G; Ben Maadi A; Buisson C; Deforge L; Weil B; Lang P
    Lancet; 1988 Nov; 2(8620):1137-8. PubMed ID: 2903346
    [No Abstract]   [Full Text] [Related]  

  • 3. DHPG treatment of kidney transplant recipients with severe CMV infection.
    Lang P; Buisson C; Rostoker G; Ben Maadi A; Fruchaud G; Deforge L; Chopin D; Abbou C; Romano P; Fleury J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2084-6. PubMed ID: 2540560
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of cytomegalovirus infections in renal transplant recipients with 9-(1,3-dihydroxy-2-propoxymethyl) guanine.
    Cantarovich M; Hiesse C; Lantz O; Fassi-Fihri S; Charpentier B; Fries D
    Transplantation; 1988 Jun; 45(6):1139-41. PubMed ID: 2837848
    [No Abstract]   [Full Text] [Related]  

  • 5. Ganciclovir for cytomegalovirus infection in renal transplant recipients.
    Lancet; 1989 Jan; 1(8631):216-7. PubMed ID: 2563118
    [No Abstract]   [Full Text] [Related]  

  • 6. Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients.
    Aulitzky WE; Tilg H; Niederwieser D; Hackl M; Meister B; Huber C
    J Infect Dis; 1988 Aug; 158(2):488-9. PubMed ID: 2841384
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolerance and efficacy of ganciclovir in the treatment of cytomegalovirus infections in immunosuppressed patients.
    Ho WG; Winston DJ; Champlin RE
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3103-6. PubMed ID: 2539690
    [No Abstract]   [Full Text] [Related]  

  • 8. Life-threatening cytomegalovirus infection treated with dihydropropoxymethylguanine.
    Creasy TS; Flower AJ; Veitch PS
    Lancet; 1986 Mar; 1(8482):675. PubMed ID: 2869359
    [No Abstract]   [Full Text] [Related]  

  • 9. Ganciclovir treatment of cytomegalovirus infections in iatrogenically immunocompromised patients.
    Keay S; Bissett J; Merigan TC
    J Infect Dis; 1987 Dec; 156(6):1016-21. PubMed ID: 2824621
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of cytomegalovirus pneumonitis with ganciclovir in renal transplantation.
    Stoffel M; Pirson Y; Squifflet JP; Lamy M; Gianello P; Alexandre GP
    Transpl Int; 1988 Dec; 1(4):181-5. PubMed ID: 2855305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHPG (Gancyclovir) improves survival in CMV pneumonia.
    Mai M; Nery J; Sutker W; Husberg B; Klintmalm G; Gonwa T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2263-5. PubMed ID: 2540565
    [No Abstract]   [Full Text] [Related]  

  • 12. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.
    Erice A; Jordan MC; Chace BA; Fletcher C; Chinnock BJ; Balfour HH
    JAMA; 1987 Jun; 257(22):3082-7. PubMed ID: 3035246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Massive cytomegalovirus pneumonia and myocarditis in a renal transplant recipient: successful treatment with DHPG.
    Shabtai M; Luft B; Waltzer WC; Anaise D; Rapaport FT
    Transplant Proc; 1988 Jun; 20(3):562-3. PubMed ID: 2837853
    [No Abstract]   [Full Text] [Related]  

  • 14. Ganciclovir treatment of cytomegalovirus disease in immunocompromised children.
    Gudnason T; Belani KK; Balfour HH
    Pediatr Infect Dis J; 1989 Jul; 8(7):436-40. PubMed ID: 2547191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients.
    Keay S; Petersen E; Icenogle T; Zeluff BJ; Samo T; Busch D; Newman CL; Buhles WC; Merigan TC
    Rev Infect Dis; 1988; 10 Suppl 3():S563-72. PubMed ID: 2847294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine).
    de Hemptinne B; Lamy ME; Salizzoni M; Cornu C; Mostin J; Fevery J; De Groote V; Otte JB
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):652-5. PubMed ID: 2831645
    [No Abstract]   [Full Text] [Related]  

  • 17. Ganciclovir therapy in iatrogenically immunosuppressed patients with cytomegalovirus disease.
    Thomson MH; Jeffries DJ
    J Antimicrob Chemother; 1989 Jun; 23 Suppl E():61-70. PubMed ID: 2550413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation.
    Stein DS; Verano AS; Levandowski RA
    Am J Gastroenterol; 1988 Jun; 83(6):684-6. PubMed ID: 2837082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganciclovir for treatment of renal transplant-associated primary cytomegalovirus pneumonia.
    Hecht DW; Snydman DR; Crumpacker CS; Werner BG; Heinze-Lacey B
    J Infect Dis; 1988 Jan; 157(1):187-90. PubMed ID: 2826608
    [No Abstract]   [Full Text] [Related]  

  • 20. Ganciclovir for treatment of cytomegalovirus disease.
    Jordan MC
    DICP; 1989 Jan; 23(1):85-6. PubMed ID: 2541567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.